A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses

Virus Research

Volumn 103, Issue 1-2, 2004, Pages 79-83

  Hurt, Aeron C ^a   Barr, Ian G ^a   Komadina, Naomi ^a   Hampson, Alan W ^a  

^a WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

A(H1N1); A(H1N2); Influenza; Neuraminidase inhibitors

Indexed keywords

SIALIDASE; ZANAMIVIR;

CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ASSAY; ENZYME INHIBITION; EPIDEMIC; FLUORESCENCE; GENETIC REASSORTMENT; INFLUENZA VIRUS A; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; VIRUS IDENTIFICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION;

ACETAMIDES; ANTIVIRAL AGENTS; FLUORESCENCE; GUANIDINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; NEURAMINIDASE; OSELTAMIVIR; PYRANS; SIALIC ACIDS; VIROLOGY; ZANAMIVIR;

INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 2442519026     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.02.017     Document Type: Conference Paper

References (20)

1. Aymard-Henry M., Coleman M.T., Dowdle W.R., Laver W.G., Schild G.C., Webster R.G. Influenza virus neuraminidase and neuraminidase-inhibition test procedures. Bull. World Health Organ. 48:1973;199-202
2. Barnett J.M., Cadman A., Gor D., Dempsey M., Walters M., Candlin A., Tisdale M., Morley P.J., Owens I.J., Fenton R.J., Lewis A.P., Claas E.C., Rimmelzwaan G.F., De Groot R., Osterhaus A.D. Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies. Antimicrob. Agents Chemother. 44:2000;78-87
3. Colman P.M., Hoyne P.A., Lawrence M.C. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J. Virol. 67:1993;2972-2980
4. Colman P.M. Influenza virus neuraminidase: structure antibodies and inhibitors. Protein Sci. 3:1994;1687-1696
5. Couch R.B., Kasel J.A., Glezen W.P., Cate T.R., Six H.R., Taber L.H., Frank A.L., Greenberg S.B., Zahradnik J.M., Keitel W.A. Influenza: its control in persons and populations. J. Infect. Dis. 153:1986;431-440
6. Fiszon B., Hannoun C. Comparison of neuraminidases of the same subtype but from different species using a new method of titration. J. Virol. Methods. 27:1990;79-90
7. Guo Y., Xu X., Cox N.J. Human influenza A (H1N2) viruses isolated from China. J. Gen. Virol. 73:1992;383-388
8. Kendal A.P., Joseph J.M., Kobayashi G., Nelson D., Reyes C.R., Ross M.R., Sarandria J.L., White R., Woodall D.F., Noble G.R., Dowdle W.R. Laboratory-based surveillance of influenza virus in the United States during the winter of 1977-1978. I. Periods of prevalence of H1N1 and H3N2 influenza A strains, their relative rates of isolation in different age groups, and detection of antigenic variants. Am. J. Epidemiol. 110:1979;449-461
9. Li X.S., Zhao C.Y., Gao H.M., Zhang Y.Q., Ishida M., Kanegae Y., Endo A., Nerome R., Omoe K., Nerome K. Origin and evolutionary characteristics of antigenic reassortant influenza A (H1N2) viruses isolated from man in China. J. Gen. Virol. 73:1992;1329-1337
10. Maassab H.F., Bryant M.L. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev. Med. Virol. 9:1999;237-244
11. Marozin S., Gregory V., Cameron K., Bennett M., Valette M., Aymard M., Foni E., Barigazzi G., Lin Y., Hay A. Antigenic and genetic diversity among swine influenza A H1N1 and H1N2 viruses in Europe. J. Gen. Virol. 83:2002;735-745
12. Nishikawa F., Sugiyama T. Direct isolation of H1N2 recombinant virus from a throat swab of a patient simultaneously infected with H1N1 and H3N2 influenza A viruses. J. Clin. Microbiol. 18:1983;425-427
13. PHLS, 2002. WHO announces the isolation of a new strain of influenza virus A(H1N2), and the vaccine composition for next winter. Press release, 6 February 2002. http://www.phls.co.uk/news/bulletins/2002/020206id.htm.
14. Poddar S.K. Influenza virus types and subtypes detection by single step single tube multiplex reverse transcription-polymerase chain reaction (RT-PCR) and agarose gel electrophoresis. J. Virol. Methods. 99:2002;63-70
15. Potier M., Mameli L., Belisle M., Dallaire L., Melancon S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N- acetylneuraminate) substrate. Anal. Biochem. 94:1979;287-296
16. Stuart-Harris, C.H., Schild, G.C., Oxford, J.S., 1985. The epidemiology of influenza. In: Influenza: The Viruses and the Disease, 2nd ed. Edward Arnold, Melbourne, pp. 188-138.
17. Tai C.Y., Escarpe P.A., Sidwell R.W., Williams M.A., Lew W., Wu H., Kim C.U., Mendel D.B. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. Antimicrob. Agents Chemother. 42:1998;3234-3241
18. Xu X., Rocha E.P., Regenery H.L., Kendal A.P., Cox N.J. Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986-1991. Virus Res. 28:1993;37-55
19. Young J.F., Palese P. Evolution of human influenza A viruses in nature: recombination contributes to genetic variation of H1N1 strains. Proc. Natl. Acad. Sci. U.S.A. 76:1979;6547-6551
20. Zhou N.N., Senne D.A., Landgraf J.S., Swenson S.L., Erickson G., Rossow K., Liu L., Yoon K., Krauss S., Webster R.G. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J. Virol. 73:1999;8851-8856